Tag Archives: highrisk

Brilinta Approved in the US to Reduce the Risk of a First Heart Attack or Stroke in High-Risk Patients with Coronary Artery Disease

Print this page June 1, 2020 — AstraZeneca’s Brilinta (ticagrelor) has been approved in the US to reduce the risk of a first heart attack or stroke in high-risk patients with coronary artery disease (CAD), the most common type of heart disease. The approval by the US Food and Drug Administration (FDA) was based on… Read More »

Novartis strikes deal with UK to provide cholesterol drug to high-risk patients

A technician at the Novartis Institutes for BioMedical Research in Cambridge, Massachusetts. David L. Ryan | The Boston Globe | Getty Images Pharmaceutical giant Novartis has reached a deal with the U.K. government to provide its late-stage cholesterol drug, inclisiran, to patients at high risk of a heart attack, the company announced Monday. The drug,… Read More »